Neurogen Biomarking Revenue

Medical and Diagnostic Laboratories • Chicago, Illinois, United States • 1-10 Employees

Neurogen Biomarking revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical and Diagnostic Laboratories industry and current estimated revenues	$2,000,000
Total funding	No funding

Key Contact at Neurogen Biomarking

Rany Aburashed

Chief Executive Officer/Founder

Company overview

Headquarters	Chicago, Illinois, United States
Website	neurogenbiomarking.com
NAICS	6215
Founded	2024
Employees	1-10

Neurogen Biomarking Email Formats

Neurogen Biomarking uses 2 email formats. The most common is {first initial} (e.g., j@neurogenbiomarking.com), used 71.4% of the time.

Format	Example	Percentage
{first initial}	j@neurogenbiomarking.com	71.4%
{first name}	john@neurogenbiomarking.com	28.6%

About Neurogen Biomarking

Neurogen Biomarking is dedicated to supporting early detection of Alzheimer’s disease and Mild Cognitive Impairment. Neurogen is on a mission to empower anyone with thinking and memory concerns with the tools, education, and motivation needed to access advanced, personalized care of patients with Alzheimer's disease – and a future with more in it.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Entry

Founder/Owner

Employees by Department

Neurogen Biomarking has 4 employees across 4 departments.

Departments

Number of employees

Funding Data

Neurogen Biomarking has never raised funding before.

Frequently asked questions

Neurogen Biomarking is located in Chicago, Illinois, US.

Neurogen Biomarking generates an estimated annual revenue of $598,885. This revenue figure reflects the company's market position and business performance in its industry.

Neurogen Biomarking has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Neurogen Biomarking was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Neurogen Biomarking has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Neurogen Biomarking

Rany Aburashed

Chief Executive Officer/Founder

4.8

40,000 users